NGeneBio Co., Ltd. (KOSDAQ:354200)
South Korea · Delayed Price · Currency is KRW 1,480.00
+43.00 (2.99%)
Last updated: Oct 31, 2025, 1:19 PM KST
NGeneBio Revenue
NGeneBio had revenue of 1.85B KRW in the quarter ending June 30, 2025, a decrease of -8.93%. This brings the company's revenue in the last twelve months to 6.63B, up 32.68% year-over-year. In the year 2024, NGeneBio had annual revenue of 5.69B with 30.80% growth.
Revenue (ttm)
6.63B
Revenue Growth
+32.68%
P/S Ratio
5.43
Revenue / Employee
118.35M
Employees
56
Market Cap
35.98B
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2024 | 5.69B | 1.34B | 30.80% |
| Dec 31, 2023 | 4.35B | -6.67B | -60.51% |
| Dec 31, 2022 | 11.02B | 3.85B | 53.81% |
| Dec 31, 2021 | 7.16B | - | - |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full Definition